These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9511053)

  • 1. Trough-only monitoring of serum vancomycin concentrations in neonates.
    Shackley F; Roberts P; Heath P; Bowler I; Saunders NJ
    J Antimicrob Chemother; 1998 Jan; 41(1):141-2. PubMed ID: 9511053
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring serum vancomycin concentrations in the treatment of Staphylococcus infections in children].
    Mariani-Kurkdjian P; Nebbad H; Aujard Y; Bingen E
    Arch Pediatr; 2008 Nov; 15(11):1625-9. PubMed ID: 18848438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.
    Kondo M; Nakagawa S; Orii S; Itohara K; Sugimoto M; Omura T; Sato Y; Imai S; Yonezawa A; Nakagawa T; Matsubara K
    Biol Pharm Bull; 2020; 43(10):1463-1468. PubMed ID: 32999156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin peak serum concentration monitoring.
    Tam VH; Moore GE; Triller DM; Briceland LL
    J Intraven Nurs; 1999; 22(6):336-42. PubMed ID: 10865602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of vancomycin in patients receiving haemodialysis: time for a change.
    Fitzpatrick F; McGaley T; Rajan L; Crowley R; Turley M; Humphreys H; Smyth E
    J Clin Pathol; 2006 Jun; 59(6):666-7. PubMed ID: 16731612
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel approach to vancomycin level monitoring: Impact of a multidisciplinary monitoring system on timing of vancomycin levels.
    Peyko V; Friedman-Jakubovics M
    Am J Health Syst Pharm; 2018 Feb; 75(3):121-126. PubMed ID: 29371192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients.
    Hammond DA; James TB; Atkinson LN; Painter JT; Lusardi K
    Crit Care Nurse; 2018 Feb; 38(1):24-28. PubMed ID: 29437075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
    Matsumoto K; Takesue Y; Ohmagari N; Mochizuki T; Mikamo H; Seki M; Takakura S; Tokimatsu I; Takahashi Y; Kasahara K; Okada K; Igarashi M; Kobayashi M; Hamada Y; Kimura M; Nishi Y; Tanigawara Y; Kimura T
    J Infect Chemother; 2013 Jun; 19(3):365-80. PubMed ID: 23673472
    [No Abstract]   [Full Text] [Related]  

  • 13. A Strategy for Dosing Vancomycin to Therapeutic Targets Using Only Trough Concentrations.
    Prybylski JP
    Clin Pharmacokinet; 2017 Mar; 56(3):263-272. PubMed ID: 27389404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of vancomycin should be monitored in burn patients.
    Dell'Aquila AM; McCulloch JA; Mamizuka EM; Santos SR; Pereira CA
    Burns; 2004 Jun; 30(4):386-7. PubMed ID: 15145199
    [No Abstract]   [Full Text] [Related]  

  • 15. Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring.
    Han HK; An H; Shin KH; Shin D; Lee SH; Kim JH; Cho SH; Kang HR; Jang IJ; Yu KS; Lim KS
    Ther Drug Monit; 2014 Oct; 36(5):606-11. PubMed ID: 24577126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic monitoring of vancomycin in routine clinical practice].
    Kacířová I; Grundmann M
    Vnitr Lek; 2014 Oct; 60(10):846-51. PubMed ID: 25382007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glycopeptides (vancomycin, teicoplanin)].
    Furuta I; Kitahashi T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():423-6. PubMed ID: 15658354
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit.
    Qian X; Du G; Weng C; Zhou H; Zhou X
    Int J Infect Dis; 2017 Jul; 60():17-22. PubMed ID: 28457752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring of vancomycin in pediatrics].
    Delicourt A; Touzin K; Lavoie A; Therrien R; Lebel D
    Med Mal Infect; 2012 Apr; 42(4):167-70. PubMed ID: 22424794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring serum vancomycin concentrations in children: is it necessary?
    Thomas MP; Steele RW
    Pediatr Infect Dis J; 1998 Apr; 17(4):351-3. PubMed ID: 9576397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.